EIF4EBP1 and breast carcinoma: DHW-208 remarkably suppressed the activation of AKT, mTOR, p70S6K, and 4EBP1 in breast cancer cell T47D and MDA-MB-231, thus inhibited PI3K/Akt/mTOR pathway.